• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Catalent, Edenbridge Pharma Enter Zydis Formulation Supply Agreement contractpharma
    August 11, 2021
    Novel formulation of glycopyrrolate will use Catalent’s Zydis ODT delivery technology for adjunctive therapy for the treatment of peptic ulcer.
  • SPI Pharma Launches UltraBurst contractpharma
    July 13, 2021
    SPI Pharma has introduced UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics—dissolution time. It is an innovative excipient platform for flash ODTs, enabling disintegration in under ten seconds.
  • Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis ODT americanpharmaceuticalreview
    December 04, 2018
    Biohaven announced positive topline results from a randomized, controlled Phase 3 clinical trial (BHV3000-303 or Study 303) evaluating the efficacy ......

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service